SCHEMBL812094

SCHEMBL812094

[CH2][CH]C(=O)OCc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 4/20 0.65
LMNA P02545 3/20 0.61
ALDH1A1 P00352 5/20 0.57
AKR1B10 O60218 2/20 0.56
AKR1B1 P15121 2/20 0.56
CA12 O43570 2/20 0.56
CA9 Q16790 2/20 0.56
CA4 P22748 1/20 0.56
CA6 P23280 1/20 0.56
CA5A P35218 1/20 0.56
CA7 P43166 1/20 0.56
CA14 Q9ULX7 1/20 0.56
CA5B Q9Y2D0 1/20 0.56
TDP1 Q9NUW8 2/20 0.55
MAPK1 P28482 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
SLC6A2 P23975 1/20 0.55
SLC6A3 Q01959 1/20 0.55
KMT2A Q03164 1/20 0.55
TTR P02766 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL28307095 0.84 HCAR2 (0.65) HCAR2LMNAALDH1A1AKR1B10AKR1B1
SCHEMBL34054 0.84 HCAR2 (0.65) HCAR2LMNAALDH1A1AKR1B10AKR1B1
SCHEMBL28230354 0.84 HCAR2 (0.65) HCAR2LMNAALDH1A1AKR1B10AKR1B1
SCHEMBL357565 0.83 HCAR2 (0.89) HCAR2LMNAALDH1A1AKR1B10AKR1B1
SCHEMBL337504 0.83 HCAR2 (0.89) HCAR2LMNAALDH1A1AKR1B10AKR1B1
SCHEMBL337503 0.83 HCAR2 (0.89) HCAR2LMNAALDH1A1AKR1B10AKR1B1
SCHEMBL9395526 0.83 HCAR2 (0.69) HCAR2LMNAALDH1A1AKR1B10AKR1B1
SCHEMBL11696680 0.82 HCAR2 (0.62) HCAR2LMNAALDH1A1AKR1B10AKR1B1
Ammonia Solution, Strong SCHEMBL11584311 0.82 HCAR2 (0.62) HCAR2LMNAALDH1A1AKR1B10AKR1B1
Ethylene SCHEMBL6402744 0.82 HCAR2 (0.62) HCAR2LMNAALDH1A1AKR1B10AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344256-B1 SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERIVATIVES AND METHODS OF PREPARATION AND USE THEREOF ELIZABETH ARDEN INT SARL (CH) 2017-04-26 EP claimed
EP-2344256-A2 SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERIVATIVES AND METHODS OF PREPARATION AND USE THEREOF Elizabeth Arden International, Sarl (CH) 2011-07-20 EP claimed
WO-2010051138-A2 SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERIVATIVES AND METHODS OF PREPARATION AND USE THEREOF PHARMA COSMETIX RESEARCH, LLC (US) 2010-05-06 WO claimed
US-20100086494-A1 SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERIVATIVES AND METHODS OF PREPARATION AND USE THEREOF PCR TECHNOLOGY HOLDINGS, LC (US) 2010-04-08 US claimed
EP-2344256-B1 SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERIVATIVES AND METHODS OF PREPARATION AND USE THEREOF ELIZABETH ARDEN INT SARL (CH) 2017-04-26 EP disclosed
US-20160151260-A1 Skin Treatments Containing Carboxylic Acid-Substituted Idebenone Derivatives and Methods of Preparation and Use Thereof CITIBANK, N.A., AS COLLATERAL AGENT 2016-06-02 US disclosed
US-9290436-B2 Compositions containing carboxylic acid-substituted derivatives ELIZABETH ARDEN, INC. (US) 2016-03-22 US disclosed
US-20130101534-A1 SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERlVATIVES AND METHODS OF PREPARATION AND USE THEREOF ELIZABETH ARDEN, INC. (US) 2013-04-25 US disclosed
US-8354550-B2 Skin treatments containing carboxylic acid-substituted idebenone derivatives and methods of preparation and use thereof ELIZABETH ARDEN, INC. (US) 2013-01-15 US disclosed
US-20120130098-A1 Skin Treatments Containing Carboxylic Acid-Substituted Idebenone Derivatives and Methods of Preparation and Use Thereof ELIZABETH ARDEN, INC. (US) 2012-05-24 US disclosed
US-8173703-B2 Skin treatments with carboxylic acid-substituted idebenone derivatives ELIZABETH ARDEN, INC. (US) 2012-05-08 US disclosed
EP-2344256-A2 SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERIVATIVES AND METHODS OF PREPARATION AND USE THEREOF Elizabeth Arden International, Sarl (CH) 2011-07-20 EP disclosed
WO-2010051138-A2 SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERIVATIVES AND METHODS OF PREPARATION AND USE THEREOF PHARMA COSMETIX RESEARCH, LLC (US) 2010-05-06 WO disclosed
US-20100086494-A1 SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERIVATIVES AND METHODS OF PREPARATION AND USE THEREOF PCR TECHNOLOGY HOLDINGS, LC (US) 2010-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130101534-A1 SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERlVATIVES AND METHODS OF PREPARATION AND USE THEREOF DECR1, ACADVL, CUTA HCAR2 427/4885LMNA 2131/4885ALDH1A1 256/4885
US-20160151260-A1 Skin Treatments Containing Carboxylic Acid-Substituted Idebenone Derivatives and Methods of Preparation and Use Thereof CUTA, HSD17B12, NDUFB10 HCAR2 326/4885LMNA 1951/4885ALDH1A1 311/4885
US-20100086494-A1 SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERIVATIVES AND METHODS OF PREPARATION AND USE THEREOF CUTA, HSD17B12, NDUFB10 HCAR2 334/4885LMNA 1821/4885ALDH1A1 312/4885
US-20120130098-A1 Skin Treatments Containing Carboxylic Acid-Substituted Idebenone Derivatives and Methods of Preparation and Use Thereof CUTA, HSD17B12, NDUFB10 HCAR2 334/4885LMNA 1821/4885ALDH1A1 312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.